Genetics of Alzheimer Disease - PowerPoint PPT Presentation

1 / 27
About This Presentation
Title:

Genetics of Alzheimer Disease

Description:

Chromosomal (Down syndrome) 1% Familial. Late-onset familial ... Down syndrome. are not at increased risk for AD. Local Arabic Experience in Genetic study ... – PowerPoint PPT presentation

Number of Views:1417
Avg rating:3.0/5.0
Slides: 28
Provided by: Jun2
Category:

less

Transcript and Presenter's Notes

Title: Genetics of Alzheimer Disease


1
Genetics of Alzheimer Disease
  • Mohammed Al- Jumah MD,FRCPC
  • King Abdulaziz Medical City
  • National Guard Health Affairs

2
Alzheimer Disease
  • Alzheimer disease (AD) is characterized by
    adult-onset slowly progressive dementia
  • The diagnosis is based on clinical bases and the
    histological findings in brain tissue of
    ß-amyloid plaques and intraneuronal
    neurofibrillary tangles.
  • No accurate clinical diagnostic test for AD
    exists.

3
Prevalence
  • AD is the most common cause of dementia
  • (Larson et al., 1984 Schoenberg et al., 1987)
  • The prevalence of dementia in individuals over
    the age of 85 years is estimated to be 25 to 45.
  • Max 1993 , Ebly et al 1994
  • Kukull et al 2002

4
Causes of Alzheimer Disease
5
Late-Onset Familial Alzheimer Disease Molecular
Genetics I
  • Well-documented association of late-onset FAD
    with the APOE e4 allele
  • APOE e4, by unknown mechanisms, appears to affect
    age of onset by shifting the onset curve toward
    an earlier age.
  • Corder et al 1993 Meyer et al 1998
  • Pericak-Vance et al 1997

6
Human Apolipoprotein E
  • Mature ApoE is a 299-amino acid polypeptide
  • (Rall et al. (1982).
  • Chromosomal locus 19q13.
  • There are 3 major isoforms of ApoE (apoE2, -E3,
    and -E4) coded for by 3 alleles.
  • The E2, E3 and E4 isoforms differ in amino acid
    sequence at 2 sites
  • (Weisgraber et al., 1981 Rall et al., 1982).

7
APOE Allele Frequencies in Controls and Patients
with AD
Modified from Jarvik et al (1996)
8
Percent of APOE Genotypes
Modified from Jarvik et al (1996)
9
ApoE4 allele Alzheimer Disease
  • ApoE4 was found to significantly associate with
    sporadic Alzheimer disease
  • Poirier et al. 1993, Meyer et al. 1998
  • The risk for AD increased from 20 to 90 and mean
    age of onset decreased from 84 to 68 years with
    increasing number of ApoE4 alleles.
  • Homozygosity for ApoE4 was virtually sufficient
    to cause AD by age 80 ???
  • Corder et al. 1993

10
ApoE4 allele Ethnic Groups
  • In 3 ethnic groups resedent in New York City,risk
    for AD was associated with ApoE4 homozygosity
    compared to the risk with ApoE3 homozygosity.
  • The risk was increased for ApoE4 heterozygous in
    Caucasians and Hispanics, but not for African
    Americans
  • Tang et al. 1996

11
ApoE4 allele Alzheimer DiseaseEthnic Groups
  • In a French group of 132 patients with late onset
    Alzheimer disease, the homozygosity for the E4
    allele was associated with AD onset at a younger
    age
  • Lucotte et al. 1994
  • In a Japanese study ApoE4 was associated with
    LOAD,the frequency was lower compared to that of
    North American families
  • Yoshizawa et al. 1994
  • In elderly Nigerians, there was no stronge
    association between E4 and Alzheimer disease
    Osuntokun
    et al. 1995

12
ApoE4 allele Alzheimer DiseaseGender Issues
  • In late-onset familial AD, women have a
    significantly higher risk of developing the
    disease than do men.
  • A significant gender difference for the ApoE4
    heterozygous genotype was observed.
  • Comparison of ApoE4 heterozygous men and women
    revealed a significant 2-fold increased risk in
    women.
  • Payami et al., 1996

13
ApoE4 allele Alzheimer Disease
  • In 13 dizygotic twin pairs discordant for
    Alzheimer disease, the frequency of the ApoE4 was
    increased in Alzheimer compared to healthy
    cotwins
  • Lannfelt et al. 1995.

14
APOE Genotypes Alzheimer Disease
  • The risk of AD is lower in subjects with the
    E2/E3 genotype, with an additional 23 of AD
    attributable to the absence of an E2 allele
  • (Corder et al. 1994).
  • It was suggested that the E2 allele may confer
    protection against Alzheimer disease and that its
    effect is not simply the absence of an E4 allele
  • ( Talbot et al. 1994).

15
(No Transcript)
16
Late-Onset Familial Alzheimer Molecular
Genetics II
  • Chromosome 12 may contain a susceptibility gene
    for late-onset AD
  • An association of 2 macro-globulin with
    late-onset FAD with both positive and negative
    association studies
  • Evidence for linkage of late-onset FAD to markers
    on chromosome 10. No gene has been identified.
  • Blacker et al 1998 , Dodel et al 2000Gibson et al
    2000Bertram et al 2000, Ertekin-Taner et al
    2000Myers et al 2000

17
Late-Onset Familial Alzheimer Disease Molecular
Genetics
18
Late-Onset Familial AD.  
  • The association of the APOE allele e4 (i.e.,
    genotypes e2/e4, e3/e4, e4/e4) with late-onset AD
    is well documented
  • The usefulness of APOE genotyping in clinical
    diagnosis and risk assessment remains unclear.
  • Presence of an APOE e4 allele or alleles is
    neither necessary nor sufficient to establish a
    diagnosis of AD.
  • Roses 1995 Saunders et al 1996
  • Welsh-Bohmer et al 1997, Mayeux et al 1998
  • Green et al 2002Romas et al 2002

19
Causes of Alzheimer Disease
20
Early-Onset Familial AD.
  • Less than 2 of families with AD have early-onset
    familial AD (EOFAD)
  • Refers to families in which multiple cases of AD
    occur with the mean age of onset usually before
    age 65
  • Age of onset is usually in the 40s or early 50s
  • Bird et al 1989. Campion et al (1999)

21
Early-Onset Familial Alzheimer Disease (EOFAD)
Molecular Genetics
Campion et al 1999
22
APOE Genotypes Alzheimer Disease (EOAD)
  • It was also found that the ApoE genotype is a
    risk factor for early-onset AD in families with
    no lesion detectable in the presenilin or APP
    gene
  • (Houlden et al. 1998)

23
Summary Genetics of AD
24
Alzheimer Disease
  • Genetic counseling
  • First-degree relatives of individuals with
    sporadic AD have about a 20 (approximately
    four-fold )lifetime risk of developing AD.
  • When several individuals in a family have AD, the
    risk is further increased.
  • EOFAD is inherited in an autosomal dominant
    manner.The risk to offspring of individuals with
    EOFAD is 50.

25
Related Genetic Counseling Issues
  • Data suggest that a young asymptomatic person
    with the APOE e4/e4 genotype may have an
    approximately 30 lifetime risk of developing AD.
  • Further refinement of this risk reveals that
    females with an APOE e4/e4 genotype have a 45
    probability of developing AD by age 73 years,
    whereas males have a 25 risk.
  • Breitner 1996 Breitner et al 1999

26
Risk to Family Members Late-Onset Sporadic
Alzheimer Disease
  • Lifetime risk of developing dementia is
    approximately 10-12.
  • For Parents, sibs, and offspring of a proband
  •  First-degree relatives of a person with AD have
    typically reported as a 20-25 risk .
  • While an association exists between AD the APOE
    e4 allele, the APOE genotype is not useful for
    accurate prediction of AD in asymptomatic
    persons.
  • Farrer et al 1989 Bird et al (1993)

27
Risk to Family MembersEarly-Onset Familial
Alzheimer Disease
  • Sibs of a proband
  • The risk to sibs depends upon the genetic status
    of the proband's parent.
  • EOFAD is inherited in an autosomal dominant
    manner.The risk to offspring of individuals with
    EOFAD is 50.
  • Offspring of a proband 
  • Individuals with early-onset familial Alzheimer
    disease have a 50 chance of transmitting the
    mutant allele to each child.

28
Down Syndrome
  • Family members of persons with Down syndrome
    are not at increased risk for AD.

29
Local Arabic Experience in Genetic study
30
Importance of Genetic Studies
  • Possible future disease marker
  • Identifying subjects at risk
  • Family DNA banking for future studies
Write a Comment
User Comments (0)
About PowerShow.com